Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma Bladder

Explore clinical trials studying Urothelial Carcinoma Bladder. Study availability and eligibility vary by location and protocol.

33 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma Bladder trial results

Completed

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

NCT05077709

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +16 more
Locations
  • City of Hope Duarte, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • University of California San Diego San Diego, California, United States
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
View all 21 locations
View Trial Details
Completed

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

NCT05375903

Conditions
Bladder Cancer, Carcinoma, Carcinoma in Situ of Bladder, +18 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • UCLA - University of California Los Angeles, California, United States
  • Florida Urology Partners, LLC Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05136898

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Urology Centers of Alabama (UCA) Homewood, Alabama, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • Medication Management Greensboro, North Carolina, United States
  • Urology Associates, P.C. Nashville, Tennessee, United States
View Trial Details
Completed

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

NCT04200963

Conditions
Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

NCT03558503

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Loma Linda University Loma Linda, California, United States
  • Providence Medical Institute Santa Monica, California, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

NCT05520099

Conditions
Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +72 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • Salinas Valley Memorial Healthcare System Salinas, California, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Memorial Health System Pembroke Pines, Florida, United States
View Trial Details
Active, Not Recruiting

A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

NCT05243550

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Arizona Urology Specialists Tucson, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Genesis Research San Diego, California, United States
  • Wichita Urology Group Wichita, Kansas, United States
View all 65 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

NCT06331299

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Genesis Research, LLC San Diego, California, United States
  • The George Washington University Medical Faculty Associates Washington D.C., District of Columbia, United States
  • Peachtree Clinical Solutions Powder Springs, Georgia, United States
View all 48 locations
View Trial Details

Related conditions